| Name | HBV-IN-23 |
|---|
| Description | HBV-IN-23 (Compound 5k) is an inhibitor of HBV DNA replication with an IC50 of 0.58 µM. HBV-IN-23 inhibits HBV DNA replication in both drug sensitive and resistant HBV strains. HBV-IN-23 shows anti-hepatocellular carcinoma cell (HCC) activities. HBV-IN-23 induces HepG2 cells apoptosis[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.58 µM (HBV DNA replication)[1] |
| References |
| Molecular Formula | C25H27N3O3S |
|---|---|
| Molecular Weight | 449.57 |